Abstract:Background B-lymphoma Moloney murine leukemia virus insertion region-1 (Bmi-1) acts as an oncogene in various tumors, and its overexpression correlates with a poor outcome in several human cancers. Ectopic expression of Bmi-1 can induce epithelial-mesenchymal transition (EMT) and enhance the motility and invasiveness of human nasopharyngeal epithelial cells (NPECs), whereas silencing endogenous Bmi-1 expression can reverse EMT and reduce the metastatic potential of nasopharyngeal cancer cells (NPCs). Mouse xenograft studies indicate that coexpression of Bmi-1 and H-Ras in breast cancer cells can induce an aggressive and metastatic phenotype with an unusual occurrence of brain metastasis; although, Bmi-1 overexpression did not result in oncogenic transformation of MCF-10A cells. However, the underlying molecular mechanism of Bmi-1-mediated progression and the metastasis of breast cancer are not fully elucidated at this time. Results Bmi-1 expression is more pronouncedly increased in primary cancer tissues compared to matched adjacent non-cancerous tissues. High Bmi-1 expression is correlated with advanced clinicopathologic classifications (T, N, and M) and clinical stages. Furthermore, a high level of Bmi-1 indicates an unfavorable overall survival and serves as a high risk marker for breast cancer. In addition, inverse transcriptional expression levels of Bmi-1 and E-cadherin are detected between the primary cancer tissues and the matched adjacent non-cancerous tissues. Higher Bmi-1 levels are found in the cancer tissue, whereas the paired adjacent non-cancer tissue shows higher E-cadherin levels. Overexpression of Bmi-1 increases the motility and invasive properties of immortalized human mammary epithelial cells, which is concurrent with the increased expression of mesenchymal markers, the decreased expression of epithelial markers, the stabilization of Snail and the dysregulation of the Akt/GSK3β pathway. Consistent with these observations, the repression of Bmi-1 in highly metastatic breast cancer cells remarkably reduces cellular motility, invasion and transformation, as well as tumorigenesis and lung metastases in nude mice. In addition, the repression of Bmi-1 reverses the expression of EMT markers and inhibits the Akt/GSK3β/Snail pathway. Conclusions This study demonstrates that Bmi-1 promotes the invasion and metastasis of human breast cancer and predicts poor survival.

Bmi1 Combines with Oncogenic KRAS to Induce Malignant Transformation of Human Pancreatic Duct Cells in Vitro.

Methyl-CpG-binding Protein 2 Drives the Furin/TGF-β1/Smad Axis to Promote Epithelial–mesenchymal Transition in Pancreatic Cancer Cells

Bmi-1 Promotes the Chemoresistance, Invasion and Tumorigenesis of Pancreatic Cancer Cells

Bmi-1 Is Related To Proliferation, Survival And Poor Prognosis In Pancreatic Cancer

Polycomb Complex Protein Bmi-1 Promotes Invasion and Metastasis of Pancreatic Cancer Stem Cells by Activating Pi3k/Akt Signaling, an Ex Vivo, in Vitro, and in Vivo Study

The Biological Features of PanIN Initiated from Oncogenic Kras Mutation in Genetically Engineered Mouse Models

BRCA2 dysfunction promotes malignant transformation of pancreatic intraepithelial neoplasia.

Activated K‐Ras and INK4a/Arf Deficiency Promote Aggressiveness of Pancreatic Cancer by Induction of EMT Consistent with Cancer Stem Cell Phenotype

Overexpression of Bmi-1 Induces the Malignant Transformation of Gastric Epithelial Cells in Vitro

Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis.

Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism.

Oncoprotein BMI‐1 Induces the Malignant Transformation of HaCaT Cells

Cooperativity of Oncogenic K-Ras and Downregulated P16/ink4a in Human Pancreatic Tumorigenesis

Overexpression of B7-H1 correlates with malignant cell proliferation in pancreatic cancer.

Oncogenic KrasG12D and Smad4/Dpc4 Haploinsufficiency Cooperate to Induce Mucinous Cystic Neoplasms and Invasive Adenocarcinoma of the Pancreas

Oncogenic KRAS, Mucin 4, and Activin A‐Mediated Fibroblast Activation Cooperate for Panin Initiation

Insulin promotes invasion and migration of KRASG12D mutant HPNE cells by upregulating MMP-2 gelatinolytic activity via ERK- and PI3K-dependent signalling

Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasia

Mutant Kras Co-Opts a Proto-Oncogenic Enhancer Network in Inflammation-Induced Metaplastic Progenitor Cells to Initiate Pancreatic Cancer

Bmi-1 Promotes Invasion and Metastasis, and Its Elevated Expression is Correlated with an Advanced Stage of Breast Cancer

MicroRNA-183 is Involved in Cell Proliferation, Survival and Poor Prognosis in Pancreatic Ductal Adenocarcinoma by Regulating Bmi-1